{"name":"Cognition Pharmaceuticals, LLC","slug":"cognition-pharmaceuticals-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"C105","genericName":"C105","slug":"c105","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"C105","genericName":"C105","slug":"c105","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQWU9uWGhsYXJkYmt0TFBpOUdpam42MEtld0p0dmxJR1VJZmFyZHNtcXRsYmE5S3BoaHlrZFl0MTh5MWNPblJ5RjdWQ3h2dU1MRXdSLUxsUlBXb3FfdEt4UUIwMmJ4R1pCb2kwOHFNZmZfdjlPcFB5MVJGcVh2RUZ2c1VxRVNYWTU5RFo2NE1DejhPSXpDMVFnN0thMWZ3TGpvUXlWdGZRU2QzSjZTR2ZkbERCempCb2M?oc=5","date":"2026-03-25","type":"regulatory","source":"Fierce Pharma","summary":"FDA approves Denali's Hunter syndrome drug, handing rare disease community a win - Fierce Pharma","headline":"FDA approves Denali's Hunter syndrome drug, handing rare disease community a win","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirgJBVV95cUxQR0w1ejJpR1N2dzhCbWZXWlZWak9BM09iSkpFWV8xbi0wYTUxNHpOMlBHc3pZNzZuTXVuTHhVQjlwbXUxMnNWVi0wcUpOUnhINkRNMXUtcF9sT3ByWUxlamE1R2VVdW5DMHROOUNwRjhDZ3hPUk1Jc0w5bXA4Qm5McVZJTklFaEJfYlF6eWhCZS12WVJYZks3RnFTVWNwRzdQWklLaWN6ZFJXS3NPQzVyN09hbEYzV1Fsc0hKQTd2bEdEeXhpU1pzN19pVGQ2c3lpM1I4NzR1SHpGZ3hYWF90VmxtaEdSajhRV0tqdjBiOURDcFA3VHU5MUtJaEp4dnJYTjJPaVUzbGZ6VGctQk1tcTg4N3NtTWN5ODhwbTNtSnoxaGJQdkdxa2NsOXBEZw?oc=5","date":"2026-01-12","type":"trial","source":"BioSpace","summary":"Enthorin Therapeutics Announces Initiation of Phase II Clinical Trial of MRM-3379 (Formerly ENT-3379) for Fragile X Syndrome by Licensing Partner Mirum Pharmaceuticals - BioSpace","headline":"Enthorin Therapeutics Announces Initiation of Phase II Clinical Trial of MRM-3379 (Formerly ENT-3379) for Fragile X Synd","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwJBVV95cUxQdjA4NjRPMVVoaVhDdmI1M2tpb0pyWlNpd3hTLVRNT01zNXVJc3NPQUpnUUEyV1pqZWNUN2lXdFdDX3dkcUNuTklNWU9NMzNQWGFXcGtRNF94QW5BTkhnYTBqN25OTmpBUVB4YXZTalg5UnN3TkNKZTdqa0ZyM2Njc21EX1MtQ0F6Y19pVHlNeXM0R21OV3dKaU01aHNOSzRBcV9CWWlmNFlHS25hQ3R5S1VKRjQyRmZWOWE2UHNRclJEakY4X1ZLekEtNmViMkFpclRzaldDT1RVaHBoanhNbUJBVG41NUxtTE1XUGxfa3JaZXQwUW54enQ1cFN3NmtwUTJHUlR0c0tHWHRLTDFKSlNuSnlEaUNRa2JqYXk5aGZKQTdOaTk0YTVyUnpKaHRiNDQwNmJkUFFJS2dhckhpN3BxNVkzRjg?oc=5","date":"2025-11-17","type":"pipeline","source":"GlobeNewswire","summary":"Dry Age-related Macular Degeneration Market Poised for - GlobeNewswire","headline":"Dry Age-related Macular Degeneration Market Poised for","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxPeUx4N1VxLVVxc28zWUFqN2xxa0gwU2xfY2FldkpYcDBDNmFxR2V0azFwVXhGN0dNZFJTd3ZXVzU4cHYtbzZHUmNxVUhKandmdlhuOXM1UHRPbTV6VUs0NEt3WnlSYkZib2JaYTcwM1dOTmlSRzJId0E4bXF1M1FCcmJ6QzFQQ0VtZFVkWGN5aGM0X0FmY1RtQWEzZlNqWWtFQ0pmUHZvNU9SV3Q5LUdiekNaZmo0U2xZNkROM2lMQ05MM1REWkMtLUlYVDg3a29idE4zU3NPekFLRHJUeTZNRzhSSFkzQUhfV0VVbWRTcEtFclpHcUxVYXdXT2JINkhubFBNSzlJSldFMHEyLTliclQwTGpyVlNEWG5XRzdR?oc=5","date":"2025-08-12","type":"trial","source":"GlobeNewswire","summary":"Cannabinoid Clinical Trial Pipeline Gains Momentum: 50+ - GlobeNewswire","headline":"Cannabinoid Clinical Trial Pipeline Gains Momentum: 50+","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxObklmOG50VlZYWUlTODZ3RjF1bk9fVVBUV1FrYmtWaWNtVzhCLW45SDRBQjBiUWV5cW9TcmRyM1FjelYwR2x0b2xlSW5vMElQQmlYSlBnMG5YX1lheGxRM3FEdzFjamVlQ01aT2drYVZMUWJ2cGo3MmFoc25ObWxqLWJWZ3dLUEtfbmVZSEtkTzcyb0gzZHh3V3FHVFE0NjFZUUtIblhvVW5xRHBuandLa3dTU1p6RmVwZFdPRGZJaUZ3RjVBQ21rSlZjdWFCQ0hMS01PQ1J5VGI3djRhZlc3R3BhTQ?oc=5","date":"2025-07-17","type":"pipeline","source":"USA Today","summary":"Best Clean Methylene Blue Supplement of 2025? Healthletic’s Pharmaceutical Precision Beats the Hype - USA Today","headline":"Best Clean Methylene Blue Supplement of 2025? Healthletic’s Pharmaceutical Precision Beats the Hype","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAJBVV95cUxQNDBiU1lFeGZxNFd0SDRTQkFzQ1lscVlHZmYzSnhHcUhDOGNFeVhrQUZlN0RFUldQUEp3a2VzekVlRi1RNUZnUFJURXJpVUhuUWFRaTU3WlR1TXBueUY5cW5QUmZ1c21UN1RVTEV0OUxTZFBTSkFZbEZmQnhpREREMnBFdXhOcFVWRnFIUTlQTzdSUWlYdXBocnNLbERuemNsZHdCaFBkUEphT1N3X1R2YS1VR0xGREROMENzdFZpQUw5WWdjU252UjRaWV9jYmlWdkhsUEV5SDBEZ1d0eXlybFNZZzZoeGZtekpqa0VoM3RHc3I4VjZIT0FnVnJtWDdubVJ4eExESUd3YWhnUy11VGl1NWJLTHFoa25tT0FWRWwyRW44b3UxZE5FWnBoSHJw?oc=5","date":"2025-07-10","type":"pipeline","source":"prnewswire.com","summary":"Comprehensive Lewy Body Dementia Market Analysis of Evolving Trends and Anticipated Growth Trajectory During the Forecast Period (2025-2034) | DelveInsight - prnewswire.com","headline":"Comprehensive Lewy Body Dementia Market Analysis of Evolving Trends and Anticipated Growth Trajectory During the Forecas","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAJBVV95cUxPd3QyQ0JRbGF1TWJBNGZBTXJRWnV1a1hHVGgwcG5DUUFfMmZGYmlYQnpab3ZBVDhkQlU4cVpOdzZpcHd6NWFPbHhJMkkwcGtDbmQ3c0xUSk1kX055NXN1QzNvbzI3Um1BQ3U2WVlWWWtWUzRZWlBob09CdENuZm4zcGRQdThqbFRZNFNBeXBldVpNZTdWMl9tMmRiMHpHMFA4NnZWblRQTVJVMXhScjRjUXVuUmdBYjFBcDA3djNOaXJ5emNId29xN21VRE16SVk0RDhWcFNfR2NQV3pDUy1fLXBWLWZMRFYyOHYxYzJpa1VEWUtlRVpPNUdSRUxraUZESzhPWEZPdHVCNFRLVTdSbG9icUJaQWhyS050WjNzckRFaWpIYWF3cjVUWjQ4dkZUYTlCRlBadjNadHl4OXJtLXQ5dDJnVmc2?oc=5","date":"2025-07-08","type":"pipeline","source":"GlobeNewswire","summary":"Alzheimer’s Therapeutics Market on Upward Trajectory Across - GlobeNewswire","headline":"Alzheimer’s Therapeutics Market on Upward Trajectory Across","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPbnhqY1c5NDBrSlpXSFlXZWhtTHQtcndBN3gtX3MzbEZUN2RzaXpTd190QjdmYjhDQmdBbkUwcGZYZlpjdmZaTWtuRnBMX1J6ODVFWEZ6QnZMVy1PVG9ScUJCN3M2emh1Zlhxek1PQnJ1X3F5NlBXbDRFQVN6ZjBKS3BDOHJDR3BseEFqOUo0UXB6MzZyLTRsc3ZPS2pvZlF3aWYwWnZRRi04ejFMalNWaUp6U19mWnRj?oc=5","date":"2025-05-27","type":"pipeline","source":"Neurology Advisor","summary":"Diagnosis and Treatment Strategies for Early Alzheimer Disease: Highlights From AAN 2025 - Neurology Advisor","headline":"Diagnosis and Treatment Strategies for Early Alzheimer Disease: Highlights From AAN 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNTGVjVUgzZ1VkcVlHMFdrTVBNWGNfQ1VyNE53LUxXQ2c2WWRHSndCZE5aRzdqalVzbHBJRGN1VDhzOFVOMjNDSzJTLVMyTnUwYWRiV1pfZmxaaThXR1AxNnUwNl9RLTdWUDFuUXhLWVhoMHJDcnR6eF9HTUdkanZscGRkVHpfQUdNWkpUNjRGTWxBcXNnZnJIMDhETTczRDlDOHVYWk11dVRoN1F3QkxILWRzUklLcm9HMGhRMlZLVEoydw?oc=5","date":"2023-09-05","type":"trial","source":"Tonix Pharmaceuticals","summary":"Tonix Pharmaceuticals Announces Topline Results from Phase 2 PREVAIL Proof-of-Concept Study of TNX-102 SL for the Management of Fibromyalgia-Type Long COVID - Tonix Pharmaceuticals","headline":"Tonix Pharmaceuticals Announces Topline Results from Phase 2 PREVAIL Proof-of-Concept Study of TNX-102 SL for the Manage","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPclBzb1VMSmxQakFYUWdZTV8tTGNoRHFUQlE0M3podV9QOTdfZjE3WkVsVHVqWTljYkl4ajBXNFMtRW9OOEF6RDhEaTFDMVVyeGY5TWpKUjBBZGROck04Y3dicFJEd21ELU9HT2t3a21hLVNZaVhTN1VtVXRFaWZYaXFBRmZlekhlRlpwMVFiQkFlbFYyaHZQbFpjTGpXbC0tN3UxUWFlalJxTEJ1VVd0bWphcXNNM0ZDWWZMOHk0UUVmZw?oc=5","date":"2023-05-03","type":"regulatory","source":"Eli Lilly","summary":"Lilly's Donanemab Significantly Slowed Cognitive and Functional Decline in Phase 3 Study of Early Alzheimer's Disease - Eli Lilly","headline":"Lilly's Donanemab Significantly Slowed Cognitive and Functional Decline in Phase 3 Study of Early Alzheimer's Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOdG1uMDlXaS03SGRTaW9rWmRpQ0RGUUVBZW9qTHhVYkEyRjgzSXotWC1UUE44emZsdWtaMW1Ja0Y3MnBZNjRwUVl1RVpBd3d0N21RcE1WTWhfSkN3NzdIdm01NThHMjV1dlJTS25GVVdGMkFJZ25KdEdhZ0xMaWdYWjVIdUV5NFdpRUpQcjlDLTkzNVZzT2RqNjlvb2JTeWRrUHQwQWc2TWNYMW1JMXJjSQ?oc=5","date":"2020-12-26","type":"pipeline","source":"Forbes","summary":"The Increasing Use Of AI In The Pharmaceutical Industry - Forbes","headline":"The Increasing Use Of AI In The Pharmaceutical Industry","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNWlVGUk45b0t1cWdnVlZhZTVHaE5ySHlKX0tnSEtmM0U4ZEFkdU1Rdjc0dUdXUnFBdHk0VVN3X1ppZmd0bHdvUy1SaHlQbmpHMms2NDB0ZWk1MnlYQmh1dDE2bDdRc2NWU2pMLUJZUm9RbUZFLVd0WUlyMlA5R09rMVZ4V3d3NGtWR2lPa0hpN21UM1NOOWRMdUEwUUdqd18yUjh3OFJrU3k?oc=5","date":"2020-01-08","type":"pipeline","source":"statnews.com","summary":"A new biotechnology and pharmaceutical industry commitment to patients and the public - statnews.com","headline":"A new biotechnology and pharmaceutical industry commitment to patients and the public","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}